Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Holland, M. Spruit, T. Troosters, M. Puhan, V. Pepin, D. Saey, M. McCormack, B. Carlin, F. Sciurba, F. Pitta, J. Wanger, N. MacIntyre, D. Kaminsky, B. Culver, S. Revill, N. Hernandes, Vasileios Andrianopoulos, C. Camillo, K. Mitchell, A. Lee, C. Hill, Sally Singh (2014)
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory diseaseEuropean Respiratory Journal, 44
E. Manali, P. Lyberopoulos, C. Triantafillidou, Likourgos Kolilekas, C. Sotiropoulou, J. Milic‐Emili, C. Roussos, S. Papiris (2010)
MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective studyBMC Pulmonary Medicine, 10
HarrisN. Stuart, J. Bishop, Clark Tjh, Dornhorst Ac, Cotes Je, Flenley Dc (1981)
LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working PartyThe Lancet, 317
W. Travis, U. Costabel, D. Hansell, T. King, D. Lynch, A. Nicholson, C. Ryerson, J. Ryu, M. Selman, A. Wells, J. Behr, D. Bouros, K. Brown, T. Colby, H. Collard, C. Cordeiro, V. Cottin, B. Crestani, M. Drent, R. Dudden, J. Egan, K. Flaherty, C. Hogaboam, Y. Inoue, T. Johkoh, D. Kim, M. Kitaichi, J. Loyd, Fernando Martinez, J. Myers, Shandra Protzko, G. Raghu, L. Richeldi, N. Sverzellati, J. Swigris, D. Valeyre (2013)
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.American journal of respiratory and critical care medicine, 188 6
K. Johannson, B. Elicker, E. Vittinghoff, D. Assayag, K. Boer, J. Golden, K. Jones, T. King, L. Koth, Joyce Lee, B. Ley, P. Wolters, H. Collard (2016)
A diagnostic model for chronic hypersensitivity pneumonitisThorax, 71
L. Gerald, W. Bailey (2002)
Global initiative for chronic obstructive lung disease.Journal of cardiopulmonary rehabilitation, 22 4
R. Albert, D. Au, A. Blackford, R. Casaburi, J. Cooper, G. Criner, P. Diaz, A. Fuhlbrigge, S. Gay, R. Kanner, N. MacIntyre, F. Martinez, R. Panos, S. Piantadosi, F. Sciurba, David Shade, T. Stibolt, J. Stoller, R. Wise, R. Yusen, J. Tonascia, A. Sternberg, W. Bailey (2016)
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.The New England journal of medicine, 375 17
C. Ryerson, P. Camp, N. Eves, M. Schaeffer, N. Syed, Satvir Dhillon, D. Jensen, F. Maltais, D. O’Donnell, N. Raghavan, Michael Roman, M. Stickland, D. Assayag, J. Bourbeau, G. Dion, C. Fell, N. Hambly, K. Johannson, M. Kalluri, N. Khalil, M. Kolb, H. Manganas, O. Morán-Mendoza, S. Provencher, W. Ramesh, J. Rolf, P. Wilcox, J. Guenette (2016)
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.Annals of the American Thoracic Society, 13 9
Martin Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C. Grinten, P. Gustafsson, R. Jensen, D. Johnson, N. MacIntyre, R. McKay, Daniel Navajas, O. Pedersen, R. Pellegrino, G. Viegi, J. Wanger (2005)
Standardisation of spirometryEuropean Respiratory Journal, 26
D. O’Donnell, S. Revill, K. Webb (2001)
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.American journal of respiratory and critical care medicine, 164 5
T. De (1982)
Parenteral nutrition before gastrointestinal surgery.The Lancet, 1
C. Ryerson, T. Urbania, L. Richeldi, J. Mooney, Joyce Lee, K. Jones, B. Elicker, L. Koth, T. King, P. Wolters, H. Collard (2012)
Prevalence and prognosis of unclassifiable interstitial lung diseaseEuropean Respiratory Journal, 42
M. Christenson (2012)
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementYearbook of Diagnostic Radiology, 2012
K. Flaherty, A. Andrei, S. Murray, C. Fraley, T. Colby, W. Travis, V. Lama, E. Kazerooni, B. Gross, G. Toews, F. Martinez (2006)
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.American journal of respiratory and critical care medicine, 174 7
(1980)
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.Annals of internal medicine, 93 3
G. Borg (1982)
Psychophysical bases of perceived exertion.Medicine and science in sports and exercise, 14 5
(2005)
ATS Pulmonary Function Laboratory Management and Procedure Manual
J. Wanger, J. Clausen, A. Coates, O. Pedersen, V. Brusasco, F. Burgos, R. Casaburi, R. Crapo, P. Enright, C. Grinten, P. Gustafsson, J. Hankinson, R. Jensen, D. Johnson, N. MacIntyre, R. McKay, Martin Miller, D. Navajas, R. Pellegrino, G. Viegi (2005)
Standardisation of the measurement of lung volumesEuropean Respiratory Journal, 26
S. Jay (2000)
Reference equations for the six-minute walk in healthy adults.American Journal of Respiratory and Critical Care Medicine, 161
D. O’Donnell, K. Webb (1993)
Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation.The American review of respiratory disease, 148 5
Marie Waatevik, A. Johannessen, F. Real, M. Aanerud, J. Hardie, P. Bakke, Tomas Eagan (2016)
Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPDEuropean Respiratory Journal, 48
(2016)
Long-Term Oxygen Treatment Trial
C. Ryerson, D. Donesky, S. Pantilat, H. Collard (2012)
Dyspnea in idiopathic pulmonary fibrosis: a systematic review.Journal of pain and symptom management, 43 4
N. MacIntyre, G. Viegi, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, P. Enright, P. Gustafsson, J. Hankinson, R. Jensen, R. McKay, D. Navajas, R. Pellegrino, J. Wanger (2005)
SERIES ''ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING'' Edited by V. Brusasco, R. Crapo and G. Viegi Number 4 in this Series Standardisation of the single-breath determination of carbon monoxide uptake in the lung
V. Lama, K. Flaherty, G. Toews, T. Colby, W. Travis, Qi Long, S. Murray, E. Kazerooni, B. Gross, J. Lynch, F. Martinez (2003)
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.American journal of respiratory and critical care medicine, 168 9
A. Faisal, B. Alghamdi, Casey Ciavaglia, A. Elbehairy, A. Elbehairy, K. Webb, J. Ora, J. Neder, D. O’Donnell (2016)
Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders.American journal of respiratory and critical care medicine, 193 3
T. King, J. Tooze, M. Schwarz, K. Brown, R. Cherniack (2001)
Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.American journal of respiratory and critical care medicine, 164 7
V. Pepin, D. Saey, L. Laviolette, F. Maltais (2007)
Exercise Capacity in Chronic Obstructive Pulmonary Disease: Mechanisms of LimitationCOPD: Journal of Chronic Obstructive Pulmonary Disease, 4
H. Collard, T. King, B. Bartelson, J. Vourlekis, M. Schwarz, K. Brown (2003)
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine, 168 5
(2002)
ATS statement: guidelines for the six-minute walk test.American journal of respiratory and critical care medicine, 166 1
O. Nishiyama, H. Taniguchi, Y. Kondoh, T. Kimura, K. Kato, T. Ogawa, F. Watanabe, S. Arizono (2007)
Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.Respiratory medicine, 101 4
Abbreviations6MWD6‐min walk distance6MWT6‐min walk testDLCOdiffusion capacity of the lung for carbon monoxideFEV1forced expiratory volume in 1 sFVCforced vital capacityILDinterstitial lung diseasePFTpulmonary function testRVresidual volumeSpO2oxygen saturationTLCtotal lung capacityINTRODUCTIONInterstitial lung disease (ILD) is a diverse group of entities that cause damage to the lung parenchyma through varying degrees of inflammation and fibrosis. Fibrotic ILDs result in restrictive ventilatory physiology and impaired gas exchange, frequently leading to exertional hypoxemia and functional limitation. The clinical and prognostic importance of exertional hypoxemia is well established, with multiple studies demonstrating a strong correlation of exertional desaturation with dyspnoea and mortality. Despite its importance, few studies have evaluated the severity, predictors and management of exertional oxygen desaturation in fibrotic ILD.Chronic obstructive pulmonary disease (COPD) is a common condition typically caused by cigarette smoking that results in a chronic inflammatory response involving the airways and lung parenchyma. COPD is characterized by persistent and progressive airflow limitation as well as impaired gas exchange that leads to dyspnoea and functional limitation. Despite similar features of dyspnoea and functional limitation in both ILD and COPD, the extent of exertional hypoxemia is often profound in patients with advanced ILD and may be more severe than in COPD. The objectives of this
Respirology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.